The levels of BIRC5/Survivin, expressed in most human cancers, but absent in normal tissues, and shown to promote proliferation and inhibition of apoptosis of cancer cells including BC [32,33], were also significantly reduced by DLL1 downregulation (2-fold). This evidence concerns the gene DLL1 and cancer.